The pathophysiological role of the adenosine A 3 receptor in the central nervous system is largely unknown. We have investigated the effects of the selective A 3 receptor agonist 2-chloro-N 6 -(3-iodobenzyl)-adenosine, Cl-IB-MECA, in cells of the astroglial lineage (human astrocytoma ADF cells). A marked reorganization of the cytoskeleton, with appearance of stress fibers and numerous cell protrusions, was found following exposure of cells to low (nM) concentrations of Cl-IB-MECA. These "trophic" effects were accompanied by induction of the expression of Rho, a small GTP-binding protein, which was virtually absent in control cells, and by changes of the intracellular distribution of the antiapoptotic protein Bcl-x L , that, in agonist-exposed cells, became specifically associated to cell protrusions. This is the first demonstration that the intracellular organization of Bcl-x L can be modulated by the activation of a G-protein-coupled membrane receptor, such as the A 3 adenosine receptor. Moreover, modulation of the astrocytic cytoskeleton by adenosine may have intriguing implications in both nervous system development and in the response of the brain to trauma and ischemia.Adenosine regulates various physiological functions through four distinct G-protein-coupled receptors (the A 1 , A 2A , A 2B and A 3 subtypes) (1) and participates in physiological neurotransmission (2). Activation of the A 1 receptor results in potent neuroprotection (2), white the A 2 receptor (particularly the A 2A subtype) has been implicated in regulation of motor functions (1, 2). On the other hand, very little is known about the A 3 receptor, which has a unique structure-activity relationship profile, tissue distribution and effector coupling (3).Insights into the possible pathophysiological role of the A 3 receptor have recently come from the use of the first really selective A 3 receptor agonists, such as N 6 -(3-iodobenzyl)-adenosine-5′-N-methyluronamide (IB-MECA, which is 50-fold selective for A 3 versus A 1 or A 2A receptor) (4) and its derivative 2-chloro-IB-MECA (Cl-IB-MECA), which shows a selectivity for the A 3 versus A 1 and A 2A receptors of 2500-and 1400-fold, respectively (5). Thanks to these selective compounds, we now know that the A 3 receptor may play a role in inflammation (6), hypotension (7), mast cell degranulation (8), and, most strikingly, in regulation of cell survival, by promoting both cell protection and cell death, depending upon the cell type and the agonist concentration (9-12). Protective effects against ischemia/ hypoxia are induced by low (nM) concentrations of A 3 receptor agonists in both cardiac myocytes and in brain (13,14). The molecular mechanisms at the basis of these effects are totally unknown. In this study, we have investigated the effects of nM Cl-IB-MECA concentrations on human cells of the astroglial lineage, a brain cell type which plays a key role in both brain development and in brain repair and remodelling following trauma and ischemia (15). In particular, based on the hypothes...